Security key
03770N101
Apogee Therapeutics, Inc. - Common Stock (APGE)
CUSIP: 03770N101
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 52,915,146
- Total 13F value
- $3,516,219,943
- Share change
- +11,146,416
- Put/Call ratio
- 7.5%
- SEC-reported price per share
- $66.45
- Number of holders
- 137
- Value change
- +$778,331,224
- Number of buys
- 111
- Number of sells
- 27
- Shares outstanding
- 62,702,889
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
137
Top holders
10
APGE full security history
Ownership snapshot
Full 13F holder table
Apogee Therapeutics, Inc. SEC filings
Apogee Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APGE - Apogee Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Venrock Adviser, LLC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership
Top 5
Venrock Adviser, LLC
14%
FMR LLC
8%
Fairmount Funds Management LLC
4.7%
Deep Track Capital, LP
3.7%
RTW INVESTMENTS, LP
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Adviser, LLC |
13F
Company
|
14%
|
$237,303,389
8,493,321 shares
|
— | 31 Dec 2023 |
| FMR LLC |
13F
Company
|
8%
|
$136,981,638
5,018,880 shares
|
— | 31 Dec 2023 |
| Fairmount Funds Management LLC |
13F
Company
|
4.7%
|
$82,176,457
2,941,176 shares
|
— | 31 Dec 2023 |
| Deep Track Capital, LP |
13F
Company
|
3.7%
|
$64,917,361
2,323,456 shares
|
— | 31 Dec 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
3.4%
|
$59,863,993
2,142,591 shares
|
— | 31 Dec 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.2%
|
$55,262,554
1,977,901 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
137
Shares
52,915,146
Rows available
137
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
137
Q1 2024 holders
137
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|